Home Cart 0 Sign in  
X

[ CAS No. 7398-42-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 7398-42-7
Chemical Structure| 7398-42-7
Chemical Structure| 7398-42-7
Structure of 7398-42-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 7398-42-7 ]

Related Doc. of [ 7398-42-7 ]

Alternatived Products of [ 7398-42-7 ]

Product Details of [ 7398-42-7 ]

CAS No. :7398-42-7 MDL No. :MFCD07783030
Formula : C10H11BrO2 Boiling Point : -
Linear Structure Formula :- InChI Key :APXOMRFLJBRHNX-UHFFFAOYSA-N
M.W : 243.10 Pubchem ID :11770640
Synonyms :

Calculated chemistry of [ 7398-42-7 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.3
Num. rotatable bonds : 4
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 55.14
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.09 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.12
Log Po/w (XLOGP3) : 2.39
Log Po/w (WLOGP) : 2.15
Log Po/w (MLOGP) : 2.72
Log Po/w (SILICOS-IT) : 3.06
Consensus Log Po/w : 2.49

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.93
Solubility : 0.285 mg/ml ; 0.00117 mol/l
Class : Soluble
Log S (Ali) : -2.58
Solubility : 0.634 mg/ml ; 0.00261 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.14
Solubility : 0.0175 mg/ml ; 0.0000721 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.77

Safety of [ 7398-42-7 ]

Signal Word:Danger Class:8
Precautionary Statements:P501-P260-P234-P264-P280-P390-P303+P361+P353-P301+P330+P331-P363-P304+P340+P310-P305+P351+P338+P310-P406-P405 UN#:3261
Hazard Statements:H314-H290 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 7398-42-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 7398-42-7 ]
  • Downstream synthetic route of [ 7398-42-7 ]

[ 7398-42-7 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 67-56-1 ]
  • [ 13737-36-5 ]
  • [ 7398-42-7 ]
YieldReaction ConditionsOperation in experiment
100% at 20℃; for 2 h; To a stirred suspension of 2-(4-(bromomethyl)phenyl)acetic acid (5.00 g, 21.8 mmol, 1.0 eq.) in methanol (75 mL) was added chlorotrimethylsilane (0.64 mL, 5.02 mmol, 0.23 eq.) at room temperature. The resulting mixture was stirred at room temperature for 2 hr, at which time the reaction was a clear colorless solution. The volatile material was removed under reduced pressure, the residue dissolved in methanol (25 mL), and the volatile material was removed under reduced pressure. This process was repeated two additional times to afford methyl 2-(4-(bromomethyl)phenyl)acetate as an orange solid (5.30 g, quantitative yield). ]H NMR (CDC13, 500 MHz) δ 7.37-7.33 (m, 2H), 7.26-7.24 (m, 2H), 4.48 (s, 2H), 3.69 (s, 3H), 3.62 (s, 2H). [Lit. /. Med. Chem. 2009, 52, 1180-9.]
99% at 20℃; for 8 h; Step (ii); 4-Bromomethylphenylacetic acid methyl ester; [Show Image] To 4-bromomethylphenylacetic acid 25g (109mmol) in methanol (120ml) was added thionyl chloride 120μl (1.64mmol) and the mixture was stirred at room temperature for 8 hours. After removal of the solvent in vacuo, the residue was neutralized with aqueous saturated sodium bicarbonate, and the mixture was extracted with ethyl acetate (300ml). The organic layer was washed aqueous saturated sodium bicarbonate, (50ml) and saturated brine (20ml), successively and dried over magnesium sulfate. The solvent was removed in vacuo to give the subtitled compound 25g as colorless crystals. Yield 99percent 1H NMR (CDCl3) δ 7.36 (2H, t, J= 8.1 Hz), 7.26 (2H, d, J= 8.1 Hz), 4.48 (2H, s), 3.69 (3H, s), 3.62 (2H, s).
98.6% at 0℃; for 1 h; [7101 Step 1: Synthesis of methyl 2-(4-(bromomethyl)phenyl)acetate[7111 2-(4-(bromomethyl)phenyl)acetic acid (3.000 g, 13.096 mmol) was dissolved in methanol (30 mL), and SOC12(1.900 mL, 26.193 mmol) was added thereto at 0 °C, followed by stirring at the same temperature for 1 hour. Then, the reaction mixture was concentrated under reduced pressure to remove the solvent. A saturated aqueous solution of sodium hydrogen carbonate was added to the concentrate, followed by extraction with ethyl acetate. The organic layer was washed with a saturated aqueous solution of sodium chloride, dried with anhydrous magnesium sulfate, and then concentrated under reduced pressure to yield the desired compound (3.140 g, 98.6 percent) as a colorless oil.
96% at 20℃; for 16 h; a) Methyl 2- r4-(bromomethyl)phenyll acetate (1-72) Thionyl chloride (48 μ; 0.65 mmol; 0.017 eq) was added to a solution of 2-[4- (bromomethyl)phenyl] acetic acid (10 g; 43.07 mmol; 1 eq) in methanol (48 mL). The reaction mixture was stirred at room temperature for 16 hours, then, concentrated to dryness. The residue was taken up in saturated sodium hydro genocarbonate (150 mL) and the resulting aqueous layer was extracted with ethyl acetate (3 x 100 mL). The combined organic layers were dried over sodium sulfate, filtered and concentrated under reduced pressure. The title compound, methyl 2-[4- (bromomethyl)phenyl] acetate was obtained in 96percent yield (10.2 g) as a white solid. 1H NMR (CDC13): δ (ppm) 3.68 (s, 2H), 3.75 (s, 3H), 4.54 (s, 2H), 7.37 (m, 4H).
79% at 60℃; for 3 h; A mixture of 2- [4-(bromomethyl)phenyl] acetic acid (3 g, 13.10 mmol), methanol (100 mL), thionyl chloride (2.3 g, 19.33 mmol) was stirred for 3 h at 60°C. The resulting mixture was concentrated under vacuum. This resulted in the title compound (2.5 g, 79percent) as colorless oil.
58% With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In tetrahydrofuran at 0 - 20℃; To a stirring solution of 14 in tetrahydrofuran (0.6 M) at 0 C. under nitrogen was added dimethylaminopyridine (0.2 eq), methanol (2.2 eq) and 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (2.2 eq). The reaction was stirred at room temperature overnight. The tetrahydrofuran was removed under reduced pressure. The resulting oil was partitioned between ethyl acetate and saturated sodium bicarbonate. The phases were separated and the organic phase was washed with saturated sodium bicarbonate (1?), 1N hydrochloric acid (1?), brine (1?), dried over sodium sulfate, filtered and concentrated in vacuo to afford the product. (58percent) 1H NMR (400 MHz, DMSO-d6) ? 7.38 (d, 2H), 7.27 (d, 2H), 4.75 (s, 2H), 3.69 (s, 2H), 3.61 (s, 3H).

Reference: [1] Patent: WO2014/66659, 2014, A1, . Location in patent: Paragraph 0616
[2] Patent: EP1939199, 2008, A1, . Location in patent: Page/Page column 96-97
[3] Journal of Medicinal Chemistry, 2009, vol. 52, # 4, p. 1180 - 1189
[4] Patent: WO2015/137750, 2015, A1, . Location in patent: Paragraph 710; 711
[5] Patent: WO2013/171281, 2013, A1, . Location in patent: Page/Page column 169
[6] Journal of Medicinal Chemistry, 2017, vol. 60, # 5, p. 1768 - 1792
[7] Patent: WO2018/96159, 2018, A1, . Location in patent: Paragraph 0307-0310
[8] Heterocyclic Communications, 2008, vol. 14, # 3, p. 129 - 136
[9] Synthesis, 2006, # 3, p. 405 - 410
[10] Journal of Medicinal Chemistry, 2017, vol. 60, # 18, p. 7703 - 7724
[11] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 10, p. 2647 - 2652
[12] Patent: US2004/254156, 2004, A1, . Location in patent: Page 21
[13] Patent: WO2007/12479, 2007, A2, . Location in patent: Page/Page column 36
[14] Patent: EP2251380, 2010, A2, . Location in patent: Page/Page column 19-20
[15] Patent: WO2012/80730, 2012, A1, . Location in patent: Page/Page column 36
[16] Patent: WO2014/178001, 2014, A1, . Location in patent: Page/Page column 59
[17] Patent: US2014/275070, 2014, A1, . Location in patent: Paragraph 0175; 0176
[18] Organic and Biomolecular Chemistry, 2016, vol. 14, # 38, p. 9055 - 9062
  • 2
  • [ 75-77-4 ]
  • [ 13737-36-5 ]
  • [ 7398-42-7 ]
YieldReaction ConditionsOperation in experiment
94.3% at 20℃; for 1 h; Inert atmosphere In a 100 mL round bottom flask, a solution of 2-(4-(bromomethyl)phenyl)acetic acid (2.5 g, 10.91 mmol) in MeOH (50 mL) was treated with TMSC1 (0.2 mL) under nitrogen atmosphere. The reaction mixture was stirred for 1 h at RT. Upon completion of reaction (TLC), the solvent was removed under reduced pressure. The residue obtained was dissolved in methanol and concentrated under reduced pressure to give the title compound. Yield: 2.5 g (94.3percent). (0727) 1H NMR (300 MHz, CDC : δ 7.36 (d, J = 8.1 Hz, 2H), 7.26 (d, J = 8.4 Hz, 2H), 4.48 (s, 2H), 3.69 (s, 3H), 3.62 (s, 2H)
Reference: [1] Patent: WO2016/57660, 2016, A1, . Location in patent: Page/Page column 77; 78
  • 3
  • [ 23786-13-2 ]
  • [ 7398-42-7 ]
Reference: [1] Journal of Organic Chemistry, 1966, vol. 31, p. 3758 - 3764
[2] Patent: US5374641, 1994, A,
  • 4
  • [ 13737-36-5 ]
  • [ 7398-42-7 ]
Reference: [1] Patent: EP1273571, 2003, A1,
  • 5
  • [ 13737-36-5 ]
  • [ 18107-18-1 ]
  • [ 7398-42-7 ]
Reference: [1] Angewandte Chemie - International Edition, 2012, vol. 51, # 48, p. 12000 - 12004[2] Angew. Chem., 2012, vol. 124, # 48, p. 12166 - 12170,4
[3] Bioorganic and Medicinal Chemistry Letters, 2000, vol. 10, # 18, p. 2149 - 2152
[4] Journal of Medicinal Chemistry, 2001, vol. 44, # 5, p. 703 - 714
  • 6
  • [ 34472-65-6 ]
  • [ 13737-36-5 ]
  • [ 7398-42-7 ]
Reference: [1] Patent: EP1389460, 2004, A1, . Location in patent: Page/Page column 28
  • 7
  • [ 622-47-9 ]
  • [ 7398-42-7 ]
Reference: [1] Journal of Organic Chemistry, 1966, vol. 31, p. 3758 - 3764
  • 8
  • [ 7398-42-7 ]
  • [ 96524-70-8 ]
YieldReaction ConditionsOperation in experiment
65% With 4-methylmorpholine N-oxide In acetonitrile at 20℃; for 3 h; A mixture of methyl 2-[4-(bromomethyl)phenyl]acetate (2.5 g, 10.28 mmol), acetonitrile (50 mL), and NMO (3.6 g, 30.73 mmol) was stirred for 3 h at room temperature. The resulting mixture was concentrated under vacuum. The residue was purified by a silica gel column eluting with ethyl acetate/petroleum ether (1/3). This resulted in the title compound (1.2 g, 65percent) as colorless oil.
45% With 4-methylmorpholine N-oxide In dimethyl sulfoxide at 20℃; for 1.5 h; Step (iii); 4-Formylphenylacetic acid methyl ester; [Show Image] To the compound 5g (20.6mmol) obtained in step (i) in dimethyl sulfoxide (15ml) was added N-methylmorpholine-N-oxide 3.61g (30.9mmol) and the mixture was stirred at room temperature for 1.5 hours. Thereto was added water 50ml and the mixture was extracted with ethyl acetate (30ml x 3). The combined organic layer was washed with water (50ml) and saturated brine (30ml), successively, dried over magnesium sulfate. The solvent was removed in vacuo, and the residue was purified by column chromatography (silica gel 100g, hexane:ethyl acetate= 10:1) to give the subtitled compound 1.65g as colorless crystals. Yield 45percent 1H NMR (CDCl3) δ 10.0 (1H, s), 7.86 (2H, t, J= 8.1 Hz), 7.46 (2H, d, J= 8.1 Hz), 3.72 (3H, s), 3.71 (2H, s).
Reference: [1] Patent: WO2018/96159, 2018, A1, . Location in patent: Paragraph 0307; 0308; 0311; 0312
[2] Patent: EP1939199, 2008, A1, . Location in patent: Page/Page column 97
[3] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 10, p. 2647 - 2652
[4] Patent: WO2012/80730, 2012, A1, . Location in patent: Page/Page column 36-37
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 7398-42-7 ]

Aryls

Chemical Structure| 13737-36-5

[ 13737-36-5 ]

4-(Bromomethyl)phenylacetic acid

Similarity: 0.88

Chemical Structure| 114772-38-2

[ 114772-38-2 ]

Methyl 2-[4-(Bromomethyl)phenyl]benzoate

Similarity: 0.82

Chemical Structure| 57486-69-8

[ 57486-69-8 ]

Methyl 2-(2-bromophenyl)acetate

Similarity: 0.82

Chemical Structure| 41841-16-1

[ 41841-16-1 ]

Methyl 2-(4-bromophenyl)acetate

Similarity: 0.81

Chemical Structure| 66270-97-1

[ 66270-97-1 ]

2-Oxo-2-phenylethyl 2-(4-(bromomethyl)phenyl)acetate

Similarity: 0.81

Bromides

Chemical Structure| 13737-36-5

[ 13737-36-5 ]

4-(Bromomethyl)phenylacetic acid

Similarity: 0.88

Chemical Structure| 114772-38-2

[ 114772-38-2 ]

Methyl 2-[4-(Bromomethyl)phenyl]benzoate

Similarity: 0.82

Chemical Structure| 57486-69-8

[ 57486-69-8 ]

Methyl 2-(2-bromophenyl)acetate

Similarity: 0.82

Chemical Structure| 41841-16-1

[ 41841-16-1 ]

Methyl 2-(4-bromophenyl)acetate

Similarity: 0.81

Chemical Structure| 66270-97-1

[ 66270-97-1 ]

2-Oxo-2-phenylethyl 2-(4-(bromomethyl)phenyl)acetate

Similarity: 0.81

Esters

Chemical Structure| 114772-38-2

[ 114772-38-2 ]

Methyl 2-[4-(Bromomethyl)phenyl]benzoate

Similarity: 0.82

Chemical Structure| 57486-69-8

[ 57486-69-8 ]

Methyl 2-(2-bromophenyl)acetate

Similarity: 0.82

Chemical Structure| 41841-16-1

[ 41841-16-1 ]

Methyl 2-(4-bromophenyl)acetate

Similarity: 0.81

Chemical Structure| 66270-97-1

[ 66270-97-1 ]

2-Oxo-2-phenylethyl 2-(4-(bromomethyl)phenyl)acetate

Similarity: 0.81

Chemical Structure| 150529-73-0

[ 150529-73-0 ]

Methyl 2-(3-bromophenyl)acetate

Similarity: 0.80

Benzyl bromides

Chemical Structure| 13737-36-5

[ 13737-36-5 ]

4-(Bromomethyl)phenylacetic acid

Similarity: 0.88

Chemical Structure| 114772-38-2

[ 114772-38-2 ]

Methyl 2-[4-(Bromomethyl)phenyl]benzoate

Similarity: 0.82

Chemical Structure| 66270-97-1

[ 66270-97-1 ]

2-Oxo-2-phenylethyl 2-(4-(bromomethyl)phenyl)acetate

Similarity: 0.81

Chemical Structure| 111128-12-2

[ 111128-12-2 ]

2-(4-(Bromomethyl)phenyl)propanoic acid

Similarity: 0.80

Chemical Structure| 4870-65-9

[ 4870-65-9 ]

α-Bromophenylacetic Acid

Similarity: 0.79